Funding & Deals
Sep 28, 2026 · 1 min read · 79,048 views
A Parkinson's biotech debut, fundraising campaign and licensing deal
M
Maya Chen
Editorial · Sep 28, 2026
Michael J. Fox Foundation backs Ariadne Bio's AB-300 & launches $2.5B campaign. SK Bio pays $1.8M for 1ST-104.
NICE backs Enhertu. CHMP recommends denecimig
← Previous
Post-Hoc Live: How much is everyone in biopharma getting paid?
Next →
US trade officials hear case on declining German drug prices
